Skip to content

Clinical trials

Phase 2 Lymphedema trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphedema Phase: Phase 2 Country / region: United States Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20032
20081
20092
20101
20121
20161
20171
20201
20242
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Recruiting4
Terminated3
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
M.D. Anderson Cancer Center3
National Center for Complementary and Integrative Health (NCCIH)2
Alice Chung1
Columbia University1
Eiger BioPharmaceuticals1
Gynecologic Oncology Group1
Kathy Miller1
Memorial Sloan Kettering Cancer Center1
PureTech1
Radiation Therapy Oncology Group1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphedema16
Breast Neoplasms3
Fibrosis2
Carcinoma, Intraductal, Noninfiltrating1
Head and Neck Neoplasms1
Neoplasms1
Postoperative Complications1
Radiation Fibrosis Syndrome1
Radiation Injuries1
Sarcoma1

Trials

Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.